Belite Bio, Inc. logo

Belite Bio, Inc. (BLTE)

Market Closed
24 Feb, 20:00
NASDAQ (CM) NASDAQ (CM)
$
186. 15
-3.11
-1.64%
$
6.31B Market Cap
- P/E Ratio
- Div Yield
115,382 Volume
- Eps
$ 189.26
Previous Close
Day Range
184.85 190.8
Year Range
49 200
Want to track BLTE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BLTE earnings report is expected in 20 days (16 Mar 2026)
Name Time Cons. EPS Eps
Belite Bio, Inc. logo
BLTE Belite Bio, Inc.
27 Mar 2026 (In 1 month)
-
-
Belite Bio, Inc. logo
BLTE Belite Bio, Inc.
16 Mar 2026 (In 2 weeks)
-
-
Belite Bio, Inc. logo
BLTE Belite Bio, Inc.
18 Nov 2025
-
-
Belite Bio, Inc. logo
BLTE Belite Bio, Inc.
11 Nov 2025
-
-
Belite Bio, Inc. logo
BLTE Belite Bio, Inc.
10 Nov 2025
-
-
Belite Bio, Inc. logo
BLTE Belite Bio, Inc.
6 Aug 2025
-
-
Belite Bio, Inc. logo
BLTE Belite Bio, Inc.
14 May 2025
-
-
Belite Bio, Inc. logo
BLTE Belite Bio, Inc.
17 Mar 2025
-
-
Belite Bio, Inc. logo
BLTE Belite Bio, Inc.
12 Nov 2024
-
-
Belite Bio, Inc. logo
BLTE Belite Bio, Inc.
12 Aug 2024
-
-
Belite Bio, Inc. logo
BLTE Belite Bio, Inc.
8 May 2024
-
-
Belite Bio, Inc. logo
BLTE Belite Bio, Inc.
11 Mar 2024
-
-
Belite Bio, Inc. logo
BLTE Belite Bio, Inc.
14 Nov 2023
-
-

BLTE Earnings Reports FAQ

What is the earnings per share (EPS) for BLTE?

EPS data for BLTE is currently not available, as Belite Bio, Inc has not reported recent earnings.

What is the company's earnings growth rate?

Belite Bio, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-03-16, based on the BLTE's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Belite Bio, Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for BLTE at this time, as Belite Bio, Inc has no recent EPS data to calculate it.